Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.265 USD | -1.40% |
|
-9.66% | -32.73% |
06-05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
05-14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.73% | 143M | |
+34.39% | 51.07B | |
-8.14% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+11.92% | 26.35B | |
-18.75% | 19.46B | |
+40.46% | 13.58B | |
+28.78% | 12.46B | |
-3.80% | 11.75B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals, Inc. Announces Management Changes